P2-131: Increased expression of survivin and its splice variants in non-small cell lung carcinoma  by Krepela, Evzen et al.
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
Copyright © 2007 by the International Association for the Study of Lung CancerS542
Introduction: EGFR-TIKs showed about twenty percent of response 
rate in refractory non-small cell lung cancer. Clinical trials of cytotoxic 
drugs and EGFR-TIKs failed to show improved survival compared 
to platinum based doublets. An antagonism between EGFR-TKIs and 
cytotoxic chemotherapy drugs was raised as a possible explanation for 
the negative results. 
Materials and Methods: The antiproliferative effects and cell cycle 
distributions after treatments with EGFR-TKIs(geﬁtinib and erlotinib) 
and cytotoxic drugs(Docetaxel, Paclitaxel, Gemcitabine) were studied 
using a cell line(NCI-H1975, adenocarcinoma of lung) harboring 
T790M mutation in exon 20 of EGFR gene. The cell viability assay and 
cell cycle analysis were performed with MTT assay and ﬂow cytome-
try. EGFR-TKIs and cytotoxic drugs were treated in different sequenc-
es to observe sequence dependent effect. Calcusyn software(Biosoft, 
Cambridge, UK) was used to calculate combination index(CI). 
Results: Various combinations of cytotoxic drugs and EGFR-TKIs 
showed different antiproliferative effects on NCI-H1975 cell line. 
Antagonisms(CI>1) were observed when EGFR-TKIs were treated 
before cytotoxic drugs(EC sequence), while synergisms(CI<1) were 
observed when cytotoxic drugs were pre-treated before EGFR-
TKIs(CE sequence). Treatment in EC sequence arrested the cells in 
G0/G1 phase and decreased the apoptotic fraction. However, treatment 
in CE sequence arrested the cells in G2/M phase and higher fractions of 
apoptotic cell death were observed. 
Conclusion: To combine EGFR-TKIs and cytotoxic drugs, sequence 
dependent anti-proliferative effects should be considered. 
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Galectin-9 is a member of the β-galactoside-binding galectin family 
proteins associated with diverse biological processes, such as apopto-
sis, cell aggregation and eosinophilic chemoattraction. Some reports 
described that galectin-9 was a possible prognostic factor in breast 
cancer and melanoma.
We have found stromal spindle cells are occasionally positive for ga-
lectin-9 in our previous study (data not shown). Herein, we investigated 
its clinicopathological signiﬁcance using lung cancer tissue microarray 
(TMA). We immunohistochemically examined the expression of galec-
tin-9 in lung cancer using TMA containing samples from 400 surgical 
cases. Cancerous stroma was microscopically recognized in 183 cases 
(109 adenocarcinoma, 70 squamous cell carcinoma and 4 adenosqua-
mous cell carcinoma cases). 
Total of 24.6 % cases (45/183) showed galectin-9 expression in stromal 
spindle cells. We examined the survival statistical signiﬁcance of ga-
lectin-9 using the log-rank test, and Kaplan-Meier curves were plotted. 
Positive immunohistochemical staining with galectin-9 was associated 
with favorer survival for patients with lung cancer (5-year survival of 
59.2% versus 31.3% p=0.0206).
Conclusion: Our data indicates that galectin-9 in cancerous stroma can 
be a better prognostic biomarker in lung cancer.
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Podoplanin is a mucin-type glycoprotein and a noble lymphatic endo-
thelial marker. Immunohistochemical staining against podoplanin is 
currently a useful tool to detect lymphatic involvement of cancer cells, 
and is widely used in a routine pathological diagnosis. By observation 
of daily cases, we have noticed stromal spindle cells are occasionally 
positive for podoplanin. To conﬁrm its presence and to investigate its 
clinical signiﬁcance, we immunohistochemically examined podoplanin 
expression using several monoclonal antibodies and tissue microarrays.
We found that stromal podoplanin expression in adenocarcinoma was 
signiﬁcantly associated with poorer prognosis (p<0.001). The prognos-
tic signiﬁcance was still high after adjustment with stage, gender, age, 
and histological differentiation (p<0.001). The expression was associ-
ated with differentiation and tended to associate with nodal metastasis. 
Also we immunohistochemically examined with 14 common cancer 
types and found that podoplanin expression was signiﬁcantly associated 
with nodal metastasis (p<.01). Our data indicates that podoplanin ex-
pression in cancerous stromal cells may play a critical role in lymphatic 
invasion of cancer cells to determine patients’ survival. 
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Background: Apoptosome pathway dysfunction in tumor cells may 
account for their apoptosis resistance and there is evidence that sur-
vivin (Sur) and some its alternative splice variants may be involved in 
regulation of this cell death pathway in malignant tumors. In this work, 
we studied the expression of transcripts encoding Sur and its splice 
variants Sur-3B, Sur-2B and Sur-ΔEx3 in non-small cell lung carci-
noma (NSCLC) tissues and lung parenchyma from surgically treated 
patients and examined the impact of survivin gene promoter genotype 
at nucleotide -31 and of the smoking status of NSCLC patients on the 
expression level of the indicated Sur transcript variants. 
Methods: The expression of mRNAs encoding Sur, Sur-3B, Sur-2B 
and Sur-ΔEx3 was quantitated by real time RT-PCR using transcript-
speciﬁc oligonucleotide primers and TaqMan ﬂuorogenic probes, and 
an input of total RNA isolated from NSCLC and lung tissues. The 
expression of Sur transcript variants was normalized against the expres-
sion of β-actin mRNA. Genotyping of the survivin gene promoter in 
NSCLC and lung tissues was performed by PCR ampliﬁcation and 
DNA sequencing of the puriﬁed PCR product with nested primers. 
Copyright © 2007 by the International Association for the Study of Lung Cancer S543
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
Results: All four investigated splice variants of the primary transcript 
of Sur gene were expressed in NSCLC and lung tissues and their 
expression level decreased in the order Sur, Sur-ΔEx3, Sur-2B and Sur-
3B. The expression of all studied Sur transcript splice variants was sub-
stantially higher in NSCLC tissues as compared to matched lungs. In 
fact, in 71 (66%), 74 (69%), 79 (74%) and 56 (52%) of 107 examined 
NSCLC patients the tumors had more than tenfold higher mRNA level 
of Sur, Sur-ΔEx3, Sur-2B and Sur-3B, respectively, as compared to 
the lungs. Neither in the tumors nor in the lungs the different genotype 
(g/g, c/g or c/c) at the position -31 in the repressor element CDE2/CHR 
of Sur gene promoter had a signiﬁcant impact on the expression of the 
investigated Sur transcript splice variants. By contrast, the expression 
of all studied Sur transcript splice variants in the tumors, but not in the 
lungs, was signiﬁcantly higher in smokers than non-smokers. 
Conclusions: The present study provides evidence that transcripts en-
coding Sur, Sur-ΔEx3, Sur-2B and Sur-3B are overexpressed in the ma-
jority of NSCLC tissues, that the single nucleotide polymorphism at the 
position -31 in the Sur gene promoter does not signiﬁcantly inﬂuence 
the level of expression of the Sur transcript splice variants in NSCLC 
and lung tissues, and that smoking may further increase the upregulated 
expression of the Sur transcript splice variants in the tumors.
This work was supported by research projects NR/7860-5 and 
MZO00064211 from the Ministry of Health, Czech Republic. 
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Background: Induction of apoptosis in cancer cells is one of the tar-
gets for the development of potential chemotherapeutic agents. Betulin, 
a lupne-type triterpene, could be puriﬁed in some plant species and had 
been shown to exert cytotoxic effects in cancer cells. The antiprolifera-
tive effect of betulin on lung cancer cells was evaluated in this study. 
Methods: The cytotoxic and anti-proliferative of betulin to lung cancer 
cells were evaluated by the MTT assay and trypan blue exclusion assay 
at three repeated tests. The morphologic changes were monitored under 
the contrast-enhanced microscope. The apoptotic effects were evalu-
ated by Annexin-V and Hoechst 33342 staining. 
Results: On our preliminary data for screening the cytotoxicitic effect 
of several pure compounds puriﬁed from plants on lung cancer cells 
were evaluated. Betulin exhibited cytotoxicitic effect on A549 lung 
cancer cells. The IC50 values of betulin on A549 cancer cells ranged 
from 5 to 10 μg/ml after 48 h of treatment. After 72 h of exposure, 
betulin (10 μg/ml) could signiﬁcantly reduced A549 cell proliferation 
to 21 ± 2.8 % of control. Betulin could also induce apoptosis in A549 
cancer cells.
Conclusions: Betulin could induce apoptosis in human lung cancer 
cells. We would like to further elucidate the anti-proliferative mecha-
nisms in vitro and in vivo of betulin to the lung cancer cells. 
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Background: Recently we reported that aryl hydrocarbon receptor 
(AhR) over-expressed in the early stage of lung adenocarcinoma (AD). 
Furthermore, AhR overexpression promoted anchorage independent 
growth of lung AD cells. To identify novel proteins associated with 
AhR overexpression, we compared the protein proﬁles in parental and 
AhR interfered AD cells H1355 with the proteomic technique. 
Methods: AhR expression in AD cells H1355 was reduced with the 
small RNA technique. Several stable clones of AhR interfered cells 
were isolated. Differentially expressed proteins in parental cells and 
AhR interfered cells were identiﬁed with two-dimensional gel electro-
phoresis followed by LC/MS analysis, and then conﬁrmed by Western 
immunoblot. The relative mRNA levels were determined with the real-
time RT-PCR method.
Results: A total of 5 proteins were identiﬁed with the proteomic 
technique and conﬁrmed with the Western immunoblot. Among these 
proteins, the changes in heat shock protein 27 and galectin-1 were the 
most dramatic. The protein and mRNA levels of these two proteins 
were negatively correlated with AhR levels in AhR interfered cells and 
ﬁve lung cancer cell lines.
Conclusions: These results suggested that AhR level negatively regu-
late expression of heat shock protein 27 and galectin-1 in lung AD. The 
role and function of these two proteins in the development of lung AD 
deserve further investigation in the future.
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Background: To assay expression of CDA, RRM1, PTEN, ERCC1, 
dCK and RRM1(-)37A/C polymorphism which have been shown 
relevant to gemcitabine resistance in two human gemcitabine-resistant 
non-small cell lung cancer cell lines A549/Gem and H460/Gem so as to 
make clear how do they vary during the course of acquiring resistance 
to gemcitabine. 
Methods: Taking the human gemcitabine-resistant non-small cell 
lung cancer cell lines A549/Gem and H460/Gem which were estab-
lished by repeated clinical serous peak concentration then low but 
gradually increasing concentration of gemcitabine in our department 
as experimental objects, we used real-time ﬂuorescent quantitative 
RT-PCR to examine expression of CDA, RRM1, PTEN, ERCC1, dCK 
and RRM1(-)37A/C polymorphism at the different time point during 
introduction process. 
